PBPramod Bonde

Pramod Bonde

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pramod Bonde has a total of 273 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Editorial

    by Pramod Bonde

  • Futuristic perspectives: novel MCS devices

    by Riya Bonde, Pramod Bonde

    Treatment of heart failure needs a firm understanding of anatomy and physiology of the circulatory system and the heart. Ancient India takes credit for the “modern concepts” of human circulation. This short review encompasses futuristic perspectives on mechanical circulatory devices (MCS). The heart is a complex structure which has evolved over millennia both in its structure and mechanical functionality. Evolving from a simple tube with peristaltic action such as in annelids, it evolved rapidly to form a more complexity as animals evolved from oceanic to terrestrial adaptation. The major advance is the innovation of placing the actuation mechanism within the blood flow path, such as in continuous flow technology (axial or centrifugal) when contrasted to the positive displacement pumps. We present novel concepts but also touch upon what we would consider as fundamental problems or paradigms that need to be addressed to move this field ahead. Finally, we propose what would be termed a “futuristic” MCS device.

  • Resonantly Coupled High-Efficiency Sensors for Assessment of Ventricular Chamber Size for Autonomous Control of Left Ventricular Assist Device

    by Yellappa Palagani, Eldar Sorkin, Riya Bonde, Piyush Bahel, Pramod Bonde

    Export Current left ventricular assist devices (LVADs) are set to a fixed rpm and are unable to adjust to physiological demands irrespective of preload or afterload. Autonomous control of LVADs has the potential to reduce septal shift, preserve right ventricle function, and meet physiological demands. A highly innovative resonantly coupled regimen is presented which can achieve this goal. We introduce sensors based on a highly sensitive relationship between transmission coefficient and spatial separation in a resonantly coupled regimen. This relationship represents a polynomial regression. A regimen of an apical sensor and multiple outflow sensors is investigated. A range of separations varying from 50–200 mm was systematically investigated. These ranges consider anatomical & physiological variation(s) in cardiac chamber size. Validation was obtained in porcine heart preparation. The polynomial regression model predicted distance between the sensors with a mean absolute percentage error of 0.77%, 1.07%, and 5.75% for the thr ee putative positions of the outflow sensors and apical sensor when compared with experimental results. A high degree of accuracy (95%) between the predicted and observed distance was obtained. Continuous measurements were done over 90 days to examine drift, with no statistically detectable change in measurements over million sampling cycles. We have demonstrated a reliable sensor methodology without drift for assessing ventricular chamber size in an LVAD setup. This has the potential to allow autonomous control of LVAD based on ventricular chamber size to address some of the adverse events.


  • Machine Learning in Cardiac Surgery: Predicting Mortality and Readmission

    by Jiheum Park, Pramod N. Bonde

    Predicting outcomes in open-heart surgery can be challenging. Unexpected readmissions, long hospital stays, and mortality have economic implications. In this study, we investigated machine learning (ML) performance in data visualization and predicting patient outcomes associated with open-heart surgery. We evaluated 8,947 patients who underwent cardiac surgery from April 2006 to January 2018. Data visualization and classification were performed at cohort-level and patient-level using clustering, correlation matrix, and seven different predictive models for predicting three outcomes (“Discharged,” “Died,” and “Readmitted”) at binary level. Cross-validation was used to train and test each dataset with the application of hyperparameter optimization and data imputation techniques. Machine learning showed promising performance for predicting mortality (AUC 0.83 ± 0.03) and readmission (AUC 0.75 ± 0.035). The cohort-level analysis revealed that ML performance is comparable to the Society of Thoracic Surgeons (STS) risk model even with limited number of samples (e.g., less than 3,000 samples for ML versus more than 100,000 samples for the STS risk models). With all cases (8,947 samples, referred as patient-level analysis), ML showed comparable performance to what has been reported for the STS models. However, we acknowledge that it remains unknown at this stage as to how the model might perform outside the institution and does not in any way constitute a comparison of the performance of the internal model with the STS model. Our study demonstrates a systematic application of ML in analyzing and predicting outcomes after open-heart surgery. The predictive utility of ML in cardiac surgery and clinical implications of the results are highlighted.


  • Open Access

    Pharyngo-esophago-gastric dysmotility in intubated patients: A comprehensive review

    by Ulaş Kumbasar, Pramod Bonde

    Postextubation swallowing dysfunction is a common phenomenon within the pharyngo-esophago-gastric dysmotility disorders. It is commonly seen after major surgery which requires endotracheal intubation for mechanical ventilation and associated with pulmonary complications which may lead to increased morbidity and mortality, prolonged hospital stay and increased cost. Thus, understanding the underlying mechanism of this phenomenon is crucial for early recognition and diagnosis of this entity, and to take preventive measures to minimize associated complications and morbidity. Literature search of the Medline database was performed to obtain related studies discussing pharyngo-esophago-gastric dysmotility. We focused on studies including PSD following major surgery and extracted data from the relevant studies, compared results, and summarized the related information. We reviewed the underlying mechanism, available diagnostic tools, risk factors, major pulmonary complications and their consequences, basic preventive measures and potential solutions related to this entity and aimed to guide physicians through decision-making process for their individual patients.

  • CASEATING CALCIFICATION OF MITRAL ANNULUS MASQUERADING AS CARDIAC TUMOR

    by Amarnath Annapureddy, Pramod Bonde, Rohan Khera

  • Impact of Preoperative Lymphopenia on Survival Following Left Ventricular Assist Device Placement

    by Kristin Stawiarski, Olayinka Agboola, Jiheum Park, Arnar Geirsson, Daniel Jacoby, Lavanya Bellumkonda, Tariq Ahmad, Josephine Chou, Forrester Lee, Abeel Mangi, et al.

    Lymphopenia has been implicated in poor outcomes in the heart failure population. However, the prognostic implication of lymphopenia in left ventricular assist device (LVAD) patients is unknown. We examine the impact of lymphopenia on all-cause mortality in this population over a 24-month period post-implantation. A total of 170 patients between June 2011 and July 2018 receiving permanent durable LVAD at a single center formed the study population. Criteria for lymphopenia on admission, defined as an absolute lymphocyte count (ALC) 4800/μl and nine with incomplete data. Survival across groups was compared with a Kaplan-Meier plot and log-rank statistics. The Cox proportional hazard model was used to examine the association between lymphopenia and 24-month all-cause mortality. In the lymphopenia group, mean ALC was 909.6 ± 331.9 versus 2073.6 ± 501.1 in the non-lymphopenic group. Twenty-four-month all-cause mortality was significantly higher in the lymphopenia group (p = 0.009). The lymphopenic patients had worse unadjusted (hazard ratio [HR] = 2.14, confidence interval [CI] = 1.19–3.82; p = 0.01) and adjusted survival (HR = 2.07, CI = 1.13–3.79; p = 0.02). Further clinical investigations are required to assess the utility of continued clinical monitoring of ALC levels beyond LVAD placement.